{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:37:22Z","timestamp":1793745442622,"version":"4.6.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03416-4","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T21:26:10Z","timestamp":1776201970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["DoE-Optimized Chitosan-Coated pH-Sensitive Liposomes for Targeted Nose-to-Brain Delivery of Temozolomide"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9521-9529","authenticated-orcid":false,"given":"Ashish","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8909-1871","authenticated-orcid":false,"given":"Harsh P.","family":"Nijhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1620-0547","authenticated-orcid":false,"given":"Khushwant S.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"2","key":"3416_CR1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21822","volume":"14","author":"GS Stoyanov","year":"2022","unstructured":"Stoyanov GS, Lyutfi E, Georgieva R, Georgiev R, Dzhenkov DL, Petkova L, et al. Reclassification of glioblastoma multiforme according to the 2021 World Health Organization classification of central nervous system tumors: a single institution report and practical significance. Cureus. 2022;14(2):e21822. https:\/\/doi.org\/10.7759\/cureus.21822.","journal-title":"Cureus"},{"issue":"7","key":"3416_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. 2023;329(7):574\u201387. https:\/\/doi.org\/10.1001\/jama.2023.0023.","journal-title":"JAMA"},{"issue":"14","key":"3416_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147974","volume":"25","author":"AA Seyhan","year":"2024","unstructured":"Seyhan AA. Circulating liquid biopsy biomarkers in glioblastoma: advances and challenges. Int J Mol Sci. 2024;25(14):7974. https:\/\/doi.org\/10.3390\/ijms25147974.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3416_CR4","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","volume":"18","author":"S Zha","year":"2024","unstructured":"Zha S, Liu H, Li H, Li H, Wong KL, All AH. Functionalized nanomaterials capable of crossing the blood-brain barrier. ACS Nano. 2024;18(3):1820\u201345. https:\/\/doi.org\/10.1021\/acsnano.3c10674.","journal-title":"ACS Nano"},{"issue":"7","key":"3416_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16070849","volume":"16","author":"F Susa","year":"2024","unstructured":"Susa F, Arpicco S, Pirri CF, Limongi T. An overview on the physiopathology of the blood\u2013brain barrier and the lipid-based nanocarriers for central nervous system delivery. Pharmaceutics. 2024;16(7):849. https:\/\/doi.org\/10.3390\/pharmaceutics16070849.","journal-title":"Pharmaceutics"},{"issue":"3","key":"3416_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/03602532.2024.2364591","volume":"57","author":"LE Russell","year":"2024","unstructured":"Russell LE, Yadav J, Maldonato BJ, Chien HC, Zou L, Vergara AG, et al. Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special populations, and the blood-brain barrier. Drug Metab Rev. 2024;57(3):244\u201371. https:\/\/doi.org\/10.1080\/03602532.2024.2364591.","journal-title":"Drug Metab Rev"},{"issue":"5","key":"3416_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/biology14050497","volume":"14","author":"M El-Tanani","year":"2025","unstructured":"El-Tanani M, Rabbani SA, Babiker R, El-Tanani Y, Satyam SM, Porntaveetus T. Emerging multifunctional biomaterials for addressing drug resistance in cancer. Biology (Basel). 2025;14(5):497. https:\/\/doi.org\/10.3390\/biology14050497.","journal-title":"Biology (Basel)"},{"issue":"25","key":"3416_CR8","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.2174\/1381612828666220603152918","volume":"28","author":"JAP Dutra","year":"2022","unstructured":"Dutra JAP, Luiz MT, Tavares Junior AG, Di Filippo LD, Carvalho SG, Chorilli M. Temozolomide: an overview of biological properties, drug delivery nanosystems, and analytical methods. Curr Pharm Des. 2022;28(25):2073\u201388. https:\/\/doi.org\/10.2174\/1381612828666220603152918.","journal-title":"Curr Pharm Des"},{"issue":"11","key":"3416_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27113507","volume":"27","author":"D Petrenko","year":"2022","unstructured":"Petrenko D, Chubarev V, Syzrantsev N, Ismail N, Merkulov V, Sologova S, et al. Temozolomide efficacy and metabolism: the implicit relevance of nanoscale delivery systems. Molecules. 2022;27(11):3507. https:\/\/doi.org\/10.3390\/molecules27113507.","journal-title":"Molecules"},{"issue":"11","key":"3416_CR10","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s11095-010-0091-0","volume":"27","author":"R Patil","year":"2010","unstructured":"Patil R, Portilla-Arias J, Ding H, Inoue S, Konda B, Hu J, et al. Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(\u03b2-L-malic acid). Pharm Res. 2010;27(11):2317\u201329. https:\/\/doi.org\/10.1007\/s11095-010-0091-0.","journal-title":"Pharm Res"},{"issue":"6","key":"3416_CR11","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.3390\/ijms25063217","volume":"25","author":"AS Karve","year":"2024","unstructured":"Karve AS, Desai JM, Gadgil SN, Dave N, Wise-Draper TM, Gudelsky GA, et al. A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome Resistance. Int J Mol Sci. 2024;25(6):3217. https:\/\/doi.org\/10.3390\/ijms25063217.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3416_CR12","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.3390\/ijms19102879","volume":"19","author":"M Da Ros","year":"2018","unstructured":"Da Ros M, De Gregorio V, Iorio AL, Giunti L, Guidi M, de Martino M, et al. Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier. Int J Mol Sci. 2018;19(10):2879. https:\/\/doi.org\/10.3390\/ijms19102879.","journal-title":"Int J Mol Sci"},{"issue":"21","key":"3416_CR13","doi-asserted-by":"publisher","first-page":"e39984","DOI":"10.1016\/j.heliyon.2024.e39984","volume":"10","author":"H Wu","year":"2024","unstructured":"Wu H, Gao W, Chen P, Wei Y, Zhao H, Wang F. Research progress of drug resistance mechanism of temozolomide in the treatment of glioblastoma. Heliyon. 2024;10(21):e39984. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39984.","journal-title":"Heliyon"},{"issue":"2","key":"3416_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/09205063.2024.2396721","volume":"36","author":"A Kumar","year":"2025","unstructured":"Kumar A, Shukla R. Current strategic arsenal and advances in nose to brain nanotheranostics for therapeutic intervention of glioblastoma multiforme. J Biomater Sci Polym Ed. 2025;36(2):212\u201346. https:\/\/doi.org\/10.1080\/09205063.2024.2396721.","journal-title":"J Biomater Sci Polym Ed"},{"issue":"20","key":"3416_CR15","doi-asserted-by":"publisher","first-page":"12401","DOI":"10.3390\/ijms232012401","volume":"23","author":"EB Postnikov","year":"2022","unstructured":"Postnikov EB, Lavrova AI, Postnov DE. Transport in the Brain Extracellular Space: Diffusion, but Which Kind? Int J Mol Sci. 2022;23(20):12401. https:\/\/doi.org\/10.3390\/ijms232012401.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3416_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrn3380","volume":"14","author":"S Millecamps","year":"2013","unstructured":"Millecamps S, Julien JP. Axonal transport deficits and neurodegenerative diseases. Nat Rev Neurosci. 2013;14(3):161\u201376. https:\/\/doi.org\/10.1038\/nrn3380.","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"3416_CR17","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/all.16064","volume":"79","author":"ZQ Huang","year":"2024","unstructured":"Huang ZQ, Liu J, Sun LY, Ong HH, Ye J, Xu Y, et al. Updated epithelial barrier dysfunction in chronic rhinosinusitis: Targeting pathophysiology and treatment response of tight junctions. Allergy. 2024;79(5):1146\u201365. https:\/\/doi.org\/10.1111\/all.16064.","journal-title":"Allergy"},{"issue":"1","key":"3416_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-025-00481-w","volume":"14","author":"I Drath","year":"2025","unstructured":"Drath I, Richter F, Feja M. Nose-to-brain drug delivery: from bench to bedside. Transl Neurodegener. 2025;14(1):23. https:\/\/doi.org\/10.1186\/s40035-025-00481-w.","journal-title":"Transl Neurodegener"},{"key":"3416_CR19","doi-asserted-by":"publisher","first-page":"9597","DOI":"10.2147\/IJN.S531451","volume":"20","author":"K Wang","year":"2025","unstructured":"Wang K, Sun J, Zhao H, Wang F, Zhang X, Zhao X, et al. Advances and Challenges in Nano-Delivery Systems for Glioblastoma Treatment: A Comprehensive Review. Int J Nanomedicine. 2025;20:9597\u2013620. https:\/\/doi.org\/10.2147\/IJN.S531451.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"3416_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1039\/D2RA06888E","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Taheri-Ledari R, Ganjali F, Mirmohammadi SS, Qazi FS, Saeidirad M, et al. Effects of morphology and size of nanoscale drug carriers on cellular uptake and internalization process: a review. RSC Adv. 2022;13(1):80\u2013114. https:\/\/doi.org\/10.1039\/D2RA06888E.","journal-title":"RSC Adv"},{"key":"3416_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.onano.2022.100103","volume":"8","author":"H Raut","year":"2022","unstructured":"Raut H, Jadhav C, Shetty K, Laxane N, Nijhawan HP, Rao GK, et al. Sorafenib tosylate novel drug delivery systems: implications of nanotechnology in both approved and unapproved indications. Open Nano. 2022;8:100103. https:\/\/doi.org\/10.1016\/j.onano.2022.100103.","journal-title":"Open Nano"},{"issue":"2","key":"3416_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/08982104.2023.2270060","volume":"34","author":"V Peddinti","year":"2024","unstructured":"Peddinti V, Rout B, Agnihotri TG, Gomte SS, Jain A. Functionalized liposomes: an enticing nanocarrier for management of glioma. J Liposome Res. 2024;34(2):349\u201367. https:\/\/doi.org\/10.1080\/08982104.2023.2270060.","journal-title":"J Liposome Res"},{"issue":"3","key":"3416_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.26599\/NBE.2024.9290095","volume":"16","author":"B Rane","year":"2024","unstructured":"Rane B, Gadekar P, Patil V, Amkar A, Jain A. Fabrication and Optimization of Febuxostat-loaded Liposomal Gel Using the Box\u2013Behnken Design for Gout Treatment. Nano Biomed Eng. 2024;16(3):484\u201397. https:\/\/doi.org\/10.26599\/NBE.2024.9290095.","journal-title":"Nano Biomed Eng"},{"key":"3416_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jconrel.2015.12.006","volume":"222","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Ren W, Zhong T, Zhang S, Huang D, Guo Y, et al. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity. J Control Release. 2016;222:56\u201366. https:\/\/doi.org\/10.1016\/j.jconrel.2015.12.006.","journal-title":"J Control Release"},{"issue":"11","key":"3416_CR25","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1080\/17425247.2023.2292678","volume":"20","author":"Z Chen","year":"2023","unstructured":"Chen Z, Wang X, Zhao N, Chen H, Guo G. Advancements in pH-responsive nanocarriers: enhancing drug delivery for tumor therapy. Expert Opin Drug Deliv. 2023;20(11):1623\u201342. https:\/\/doi.org\/10.1080\/17425247.2023.2292678.","journal-title":"Expert Opin Drug Deliv"},{"key":"3416_CR26","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02930-7","volume":"25","author":"HP Nijhawan","year":"2024","unstructured":"Nijhawan HP, Shyamsundar P, Prabhakar B, Yadav KS. PEGylated pH-responsive liposomes for enhancing the intracellular uptake and cytotoxicity of paclitaxel in MCF-7 breast cancer cells. AAPS PharmSciTech. 2024;25:216. https:\/\/doi.org\/10.1208\/s12249-024-02930-7.","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"3416_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061128","volume":"14","author":"H Alrbyawi","year":"2022","unstructured":"Alrbyawi H, Poudel I, Annaji M, Boddu SHS, Arnold RD, Tiwari AK, et al. pH-sensitive liposomes for enhanced cellular uptake and cytotoxicity of daunorubicin in melanoma (B16-BL6) cell lines. Pharmaceutics. 2022;14(6):1128. https:\/\/doi.org\/10.3390\/pharmaceutics14061128.","journal-title":"Pharmaceutics"},{"issue":"3","key":"3416_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.145537","volume":"319","author":"SS Deshmukh","year":"2025","unstructured":"Deshmukh SS, Nijhawan HP, Yadav KS. Chitosan-based copolymeric nanocarrier systems: a novel paradigm for targeted breast cancer therapy. Int J Biol Macromol. 2025;319(3):145537. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145537.","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"3416_CR29","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3390\/vaccines11081333","volume":"11","author":"SC Gaglio","year":"2023","unstructured":"Gaglio SC, Perduca M, Zipeto D, Bardi G. Efficiency of chitosan nanocarriers in vaccinology for mucosal immunization. Vaccines (Basel). 2023;11(8):1333. https:\/\/doi.org\/10.3390\/vaccines11081333.","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"3416_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101686","volume":"13","author":"N Aibani","year":"2021","unstructured":"Aibani N, Rai R, Patel P, Cuddihy G, Wasan EK. Chitosan nanoparticles at the biological interface: implications for drug delivery. Pharmaceutics. 2021;13(10):1686. https:\/\/doi.org\/10.3390\/pharmaceutics13101686.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3416_CR31","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1080\/10717544.2018.1494226","volume":"25","author":"L Chu","year":"2018","unstructured":"Chu L, Wanga A, Ni L, Yan X, Song Y, Zhao M, et al. Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting. Drug Deliv. 2018;25(1):1634\u201341. https:\/\/doi.org\/10.1080\/10717544.2018.1494226.","journal-title":"Drug Deliv"},{"issue":"11","key":"3416_CR32","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1021\/acs.molpharmaceut.6b00586","volume":"13","author":"A Khan","year":"2016","unstructured":"Khan A, Imam SS, Aqil M, Ahad A, Sultana Y, Ali A, et al. Brain targeting of temozolomide via the intranasal route using lipid-based nanoparticles: brain pharmacokinetic and scintigraphic analyses. Mol Pharm. 2016;13(11):3773\u201382. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00586.","journal-title":"Mol Pharm"},{"issue":"3","key":"3416_CR33","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1021\/acs.molpharmaceut.0c00911","volume":"18","author":"L Wang","year":"2021","unstructured":"Wang L, Tang S, Yu Y, Lv Y, Wang A, Yan X, et al. Intranasal delivery of temozolomide-conjugated gold nanoparticles functionalized with anti-EphA3 for glioblastoma targeting. Mol Pharm. 2021;18(3):915\u201327. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00911.","journal-title":"Mol Pharm"},{"key":"3416_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.965789","volume":"13","author":"S Wang","year":"2022","unstructured":"Wang S, Yu Y, Wang A, Duan X, Sun Y, Wang L, et al. Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration. Front Pharmacol. 2022;13:965789. https:\/\/doi.org\/10.3389\/fphar.2022.965789.","journal-title":"Front Pharmacol"},{"key":"3416_CR35","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.ijbiomac.2018.05.079","volume":"116","author":"A Khan","year":"2018","unstructured":"Khan A, Aqil M, Imam SS, Ahad A, Sultana Y, Ali A, et al. Temozolomide loaded nano lipid based chitosan hydrogel for nose to brain delivery: characterization, nasal absorption, histopathology and cell line study. Int J Biol Macromol. 2018;116:1260\u20137. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.05.079.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"3416_CR36","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s13346-022-01220-8","volume":"13","author":"P Sandbhor","year":"2023","unstructured":"Sandbhor P, Goda J, Mohanty B, Gera P, Yadav S, Chekuri G, et al. Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model. Drug Deliv Transl Res. 2023;13(2):608\u201326. https:\/\/doi.org\/10.1007\/s13346-022-01220-8.","journal-title":"Drug Deliv Transl Res"},{"key":"3416_CR37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jconrel.2023.01.070","volume":"355","author":"LR Michels","year":"2023","unstructured":"Michels LR, Fachel FNS, Schuh RS, Azambuja JH, de Souza PO, Gelsleichter NE, et al. Nasal administration of a temozolomide-loaded thermoresponsive nanoemulsion reduces tumor growth in a preclinical glioblastoma model. J Control Release. 2023;355:343\u201357. https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.070.","journal-title":"J Control Release"},{"key":"3416_CR38","doi-asserted-by":"publisher","first-page":"106390","DOI":"10.1016\/j.jddst.2024.106390","volume":"102","author":"JL Duarte","year":"2024","unstructured":"Duarte JL, Di Filippo LD, Azevedo Vilella KJ, Paes Dutra JA, Ribeiro DM, Freitas da Silva M, et al. Chitosan-coated nanoemulsion for intranasal administration increases temozolomide mucosal permeation, cellular uptake, and In vitro cytotoxicity in glioblastoma multiforme cells. J Drug Deliv Sci Technol. 2024;102:106390. https:\/\/doi.org\/10.1016\/j.jddst.2024.106390.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3416_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.114898","volume":"255","author":"Y Qu","year":"2025","unstructured":"Qu Y, Zhao J, Ma L, Wang X, Sun F, Li Y, et al. Intranasal delivery of temozolomide and disulfiram in situ gel combined with copper for enhanced glioblastoma therapy. Colloids Surf B Biointerfaces. 2025;255:114898. https:\/\/doi.org\/10.1016\/j.colsurfb.2025.114898.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"2","key":"3416_CR40","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s13346-025-01895-9","volume":"16","author":"M Koh","year":"2026","unstructured":"Koh M, Lee JE, Ye E, Lee S, Kim HL, Song HE, et al. Intranasal administration of temozolomide conjugated nanoparticles with transcranial magnetic stimulation improves the survival in glioblastoma xenograft models. Drug Deliv Transl Res. 2026;16(2):509\u201321. https:\/\/doi.org\/10.1007\/s13346-025-01895-9.","journal-title":"Drug Deliv Transl Res"},{"issue":"10","key":"3416_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4615","volume":"33","author":"LR Michels","year":"2019","unstructured":"Michels LR, Fachel FNS, Azambuja JH, Gelsleichter NE, Braganhol E, Teixeira HF. HPLC\u2013UV method for temozolomide determination in complex biological matrices: application for in vitro, ex vivo and in vivo studies. Biomed Chromatogr. 2019;33(10):e4615. https:\/\/doi.org\/10.1002\/bmc.4615.","journal-title":"Biomed Chromatogr"},{"key":"3416_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejpb.2023.03.004","volume":"186","author":"T Waghule","year":"2023","unstructured":"Waghule T, Laxmi Swetha K, Roy A, Narayan Saha R, Singhvi G. Exploring temozolomide encapsulated PEGylated liposomes and lyotropic liquid crystals for effective treatment of glioblastoma: in-vitro, cell line, and pharmacokinetic studies. Eur J Pharm Biopharm. 2023;186:18\u201329. https:\/\/doi.org\/10.1016\/j.ejpb.2023.03.004.","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"3416_CR43","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/20415990.2024.2342771","volume":"15","author":"HP Nijhawan","year":"2024","unstructured":"Nijhawan HP, Prabhakar B, Yadav KS. Central composite design augmented quality-by-design-based systematic formulation of erlotinib hydrochloride-loaded chitosan-poly (lactic-co-glycolic acid) nanoparticles. Ther Deliv. 2024;15(6):427\u201347. https:\/\/doi.org\/10.1080\/20415990.2024.2342771.","journal-title":"Ther Deliv"},{"key":"3416_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106253","volume":"101","author":"KS Yadav","year":"2024","unstructured":"Yadav KS, Nijhawan HP, Gite P, Shetty S. Nanofiber power: reinforcing in-situ hydrogel for enhanced rivastigmine delivery. J Drug Deliv Sci Technol. 2024;101:106253. https:\/\/doi.org\/10.1016\/j.jddst.2024.106253.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"4","key":"3416_CR45","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02560-5","volume":"24","author":"H Bhargave","year":"2023","unstructured":"Bhargave H, Nijhawan H, Yadav KS. PEGylated erlotinib HCl injectable nanoformulation for improved bioavailability. AAPS PharmSciTech. 2023;24(4):101. https:\/\/doi.org\/10.1208\/s12249-023-02560-5.","journal-title":"AAPS PharmSciTech"},{"key":"3416_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s12668-025-02296-5","volume":"16","author":"D Singhal","year":"2026","unstructured":"Singhal D, Nijhawan HP, Yadav KS. Enhanced ocular delivery of bimatoprost using surfactant and lipid-based bilosomes in situ gel in rabbits and glaucoma-induced Wistar rats. BioNanoSci. 2026;16:77. https:\/\/doi.org\/10.1007\/s12668-025-02296-5.","journal-title":"BioNanoSci"},{"issue":"8","key":"3416_CR47","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/10837450.2023.2251148","volume":"28","author":"KS Yadav","year":"2023","unstructured":"Yadav KS, Raut HC, Nijhawan HP. Inhalable spray-dried polycaprolactone-based microparticles of sorafenib tosylate with promising efficacy on A549 cells. Pharm Dev Technol. 2023;28(8):755\u201367. https:\/\/doi.org\/10.1080\/10837450.2023.2251148.","journal-title":"Pharm Dev Technol"},{"issue":"3","key":"3416_CR48","doi-asserted-by":"publisher","first-page":"429","DOI":"10.26599\/NBE.2024.9290084","volume":"16","author":"M Sabareesh","year":"2024","unstructured":"Sabareesh M, Rajangam J, Yanadaiah JP. Formulation of Enalapril Maleate Nanoproniosomal Gels and Their Pharmacokinetic Evaluations in Hypertensive Albino Wistar Rats: Ex Vivo and In Vivo Approaches. Nano Biomed Eng. 2024;16(3):429\u201342. https:\/\/doi.org\/10.26599\/NBE.2024.9290084.","journal-title":"Nano Biomed Eng"},{"issue":"2","key":"3416_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/ph18020195","volume":"18","author":"JD Steyn","year":"2025","unstructured":"Steyn JD, Haasbroek-Pheiffer A, Pheiffer W, Weyers M, van Niekerk SE, Hamman JH, et al. Evaluation of drug permeation enhancement by using in vitro and ex vivo models. Pharmaceuticals (Basel). 2025;18(2):195. https:\/\/doi.org\/10.3390\/ph18020195.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"15","key":"3416_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202200340","volume":"11","author":"C Butnarasu","year":"2022","unstructured":"Butnarasu C, Petrini P, Bracotti F, Visai L, Guagliano G, Fiorio Pla A, et al. Mucosomes: intrinsically mucoadhesive glycosylated mucin nanoparticles as multi-drug delivery platform. Adv Healthc Mater. 2022;11(15):e2200340. https:\/\/doi.org\/10.1002\/adhm.202200340.","journal-title":"Adv Healthc Mater"},{"issue":"10","key":"3416_CR51","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3390\/ph18101498","volume":"18","author":"NN Porfiryeva","year":"2025","unstructured":"Porfiryeva NN, Zlotver I, Sosnik A. Combined Effect of Size and Charge on the Interaction of Nanoparticles with Mucus-Mimicking Mucin Hydrogels. Pharmaceuticals (Basel). 2025;18(10):1498. https:\/\/doi.org\/10.3390\/ph18101498.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3416_CR52","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jcis.2016.10.090","volume":"488","author":"VN Boya","year":"2017","unstructured":"Boya VN, Lovett R, Setua S, Gandhi V, Nagesh PKB, Khan S, et al. Probing mucin interaction behavior of magnetic nanoparticles. J Colloid Interface Sci. 2017;488:258\u201368. https:\/\/doi.org\/10.1016\/j.jcis.2016.10.090.","journal-title":"J Colloid Interface Sci"},{"issue":"9","key":"3416_CR53","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1007\/s10103-022-03634-9","volume":"37","author":"M Nour","year":"2022","unstructured":"Nour M, Hamdy O, Faid AH, Eltayeb EA, Zaky AA. Utilization of gold nanoparticles for the detection of squamous cell carcinoma of the tongue based on laser-induced fluorescence and diffuse reflectance characteristics: an in vitro study. Lasers Med Sci. 2022;37(9):3551\u201360. https:\/\/doi.org\/10.1007\/s10103-022-03634-9.","journal-title":"Lasers Med Sci"},{"issue":"3","key":"3416_CR54","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1080\/01635581.2021.1952438","volume":"74","author":"M Gautam","year":"2022","unstructured":"Gautam M, Gabrani R. Combinatorial effect of temozolomide and naringenin in human glioblastoma multiforme cell lines. Nutr Cancer. 2022;74(3):1071\u20138. https:\/\/doi.org\/10.1080\/01635581.2021.1952438.","journal-title":"Nutr Cancer"},{"issue":"1","key":"3416_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/chromatography3010004","volume":"3","author":"CJ Peer","year":"2016","unstructured":"Peer CJ, Ronner L, Rodgers L, McCully CML, Warren KE, Figg WD. Quantification of temozolomide in nonhuman primate fluids by isocratic ultra-high performance liquid chromatography-tandem mass spectrometry to study brain tissue penetration following intranasal or intravenous delivery. Separations. 2016;3(1):4. https:\/\/doi.org\/10.3390\/chromatography3010004.","journal-title":"Separations"},{"issue":"1","key":"3416_CR56","doi-asserted-by":"publisher","first-page":"100290","DOI":"10.1016\/j.xpro.2020.100290","volume":"2","author":"KM Eyme","year":"2021","unstructured":"Eyme KM, Carvalho L, Badr CE. Intranasal delivery of experimental compounds in orthotopic brain tumor mouse models. STAR Protocols. 2021;2(1):100290. https:\/\/doi.org\/10.1016\/j.xpro.2020.100290.","journal-title":"STAR Protocols"},{"key":"3416_CR57","doi-asserted-by":"publisher","unstructured":"Yadav KS, Nijhawan HP, Nirale P, Singhal D, Soni G. Efficient nose-to-brain delivery of chitosan-coated resveratrol nanoemulsion in rats: Formulation optimized using D-optimal mixture design. J Dispers Sci Technol. 2025;1\u201315. https:\/\/doi.org\/10.1080\/01932691.2025.2483899","DOI":"10.1080\/01932691.2025.2483899"},{"key":"3416_CR58","doi-asserted-by":"publisher","unstructured":"Nijhawan HP, Vyas J, Verma P, Yadav KS. Hyaluronic acid-coated cubosomal in situ gel for Brimonidine Tartrate: a sustained delivery system with enhanced ocular bioavailability and intraocular pressure reduction. J Biomater Sci Polym Ed. 2025;1\u201334. https:\/\/doi.org\/10.1080\/09205063.2025.2543071","DOI":"10.1080\/09205063.2025.2543071"},{"key":"3416_CR59","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jconrel.2024.08.030","volume":"375","author":"PS Wei","year":"2024","unstructured":"Wei PS, Thota N, John G, Chang E, Lee S, Wang Y, et al. Enhancing RNA-lipid nanoparticle delivery: organ- and cell-specificity and barcoding strategies. J Control Release. 2024;375:366\u201388. https:\/\/doi.org\/10.1016\/j.jconrel.2024.08.030.","journal-title":"J Control Release"},{"issue":"6","key":"3416_CR60","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1080\/03639045.2017.1421661","volume":"44","author":"J Vanza","year":"2018","unstructured":"Vanza J, Jani P, Pandya N, Tandel H. Formulation and statistical optimization of intravenous temozolomide-loaded PEGylated liposomes to treat glioblastoma multiforme by three-level factorial design. Drug Dev Ind Pharm. 2018;44(6):923\u201333. https:\/\/doi.org\/10.1080\/03639045.2017.1421661.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"3416_CR61","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/08982104.2023.2226216","volume":"34","author":"H Nsairat","year":"2024","unstructured":"Nsairat H, Ibrahim AA, Jaber AM, Abdelghany S, Atwan R, Shalan N, et al. Liposome bilayer stability: emphasis on cholesterol and its alternatives. J Liposome Res. 2024;34(1):178\u2013202. https:\/\/doi.org\/10.1080\/08982104.2023.2226216.","journal-title":"J Liposome Res"},{"issue":"2","key":"3416_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11020086","volume":"11","author":"FA Bruinsmann","year":"2019","unstructured":"Bruinsmann FA, Pigana S, Aguirre T, Souto GD, Pereira GG, Bianchera A, et al. Chitosan-coated nanoparticles: effect of chitosan molecular weight on nasal transmucosal delivery. Pharmaceutics. 2019;11(2):86. https:\/\/doi.org\/10.3390\/pharmaceutics11020086.","journal-title":"Pharmaceutics"},{"key":"3416_CR63","doi-asserted-by":"publisher","first-page":"121700","DOI":"10.1016\/j.ijpharm.2022.121700","volume":"619","author":"G Yenduri","year":"2022","unstructured":"Yenduri G, Costa AP, Xu X, Burgess DJ. Impact of critical process parameters and critical material attributes on the critical quality attributes of liposomal formulations prepared using continuous processing. Int J Pharm. 2022;619:121700. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121700.","journal-title":"Int J Pharm"},{"key":"3416_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2025.110364","volume":"255","author":"N Rajbhar","year":"2025","unstructured":"Rajbhar N, Singhal D, Nijhawan HP, Verma P, Soni G, Yadav KS. Bilosomes as a novel ocular drug delivery system: assessing the material attributes, process parameters, and quality attributes. Exp Eye Res. 2025;255:110364. https:\/\/doi.org\/10.1016\/j.exer.2025.110364.","journal-title":"Exp Eye Res"},{"key":"3416_CR65","doi-asserted-by":"publisher","unstructured":"Singh R, Harsh \u00b7, Nijhawan P, Khushwant \u00b7, Yadav S, Yadav KS. Breaking the Barrier: Enhanced Transdermal Benztropine Delivery Using Nanoparticle-loaded Dissolving Microneedles. BioNanoSci. 2025; 15:474. https:\/\/doi.org\/10.1007\/s12668-025-02077-0","DOI":"10.1007\/s12668-025-02077-0"},{"issue":"3-4","key":"3416_CR66","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12013-017-0792-7","volume":"75","author":"WK Subczynski","year":"2017","unstructured":"Subczynski WK, Pasenkiewicz-Gierula M, Widomska J, Mainali L, Raguz M. High cholesterol\/low cholesterol: effects in biological membranes: a review. Cell Biochem Biophys. 2017;75(3\u20134):369\u201385. https:\/\/doi.org\/10.1007\/s12013-017-0792-7.","journal-title":"Cell Biochem Biophys"},{"issue":"11","key":"3416_CR67","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1016\/j.bbamem.2018.05.018","volume":"1860","author":"NB Leite","year":"2018","unstructured":"Leite NB, Martins DB, Fazani VE, Vieira MR, dos Santos Cabrera MP. Cholesterol modulates curcumin partitioning and membrane effects. Biochim Biophys Acta Biomembr. 2018;1860(11):2320\u20138. https:\/\/doi.org\/10.1016\/j.bbamem.2018.05.018.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"3416_CR68","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/919658","volume":"1","author":"SS Omar Zaki","year":"2015","unstructured":"Omar Zaki SS, Ibrahim MN, Katas H. Particle size affects concentration-dependent cytotoxicity of chitosan nanoparticles towards mouse hematopoietic stem cells. J Nanotechnol. 2015;1:919658. https:\/\/doi.org\/10.1155\/2015\/919658.","journal-title":"J Nanotechnol"},{"key":"3416_CR69","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.carbpol.2015.07.072","volume":"134","author":"SH Chang","year":"2015","unstructured":"Chang SH, Lin HTV, Wu GJ, Tsai GJ. pH Effects on solubility, zeta potential, and correlation between antibacterial activity and molecular weight of chitosan. Carbohydr Polym. 2015;134:74\u201381. https:\/\/doi.org\/10.1016\/j.carbpol.2015.07.072.","journal-title":"Carbohydr Polym"},{"key":"3416_CR70","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/pen.26261","volume":"63","author":"S Benamer Oudih","year":"2023","unstructured":"Benamer Oudih S, Tahtat D, Nacer Khodja A, Mahlous M, Hammache Y, Guittoum AE, et al. Chitosan nanoparticles with controlled size and zeta potential. Polym Eng Sci. 2023;63:1011\u201321. https:\/\/doi.org\/10.1002\/pen.26261.","journal-title":"Polym Eng Sci"},{"issue":"8","key":"3416_CR71","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/j.bpj.2013.08.042","volume":"105","author":"BN Olsen","year":"2013","unstructured":"Olsen BN, Bielska AA, Lee T, Daily MD, Covey DF, Schlesinger PH, et al. The structural basis of cholesterol accessibility in membranes. Biophys J. 2013;105(8):1838\u201347. https:\/\/doi.org\/10.1016\/j.bpj.2013.08.042.","journal-title":"Biophys J"},{"key":"3416_CR72","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10311-020-00963-5","volume":"18","author":"R Parhi","year":"2020","unstructured":"Parhi R. Drug delivery applications of chitin and chitosan: a review. Environ Chem Lett. 2020;18:577\u201394. https:\/\/doi.org\/10.1007\/s10311-020-00963-5.","journal-title":"Environ Chem Lett"},{"issue":"2","key":"3416_CR73","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-018-1274-y","volume":"20","author":"GK Eleftheriadis","year":"2019","unstructured":"Eleftheriadis GK, Mantelou P, Karavasili C, Chatzopoulou P, Katsantonis D, Irakli M, et al. Development and characterization of a self-nanoemulsifying drug delivery system comprised of rice bran oil for poorly soluble drugs. AAPS PharmSciTech. 2019;20(2):78. https:\/\/doi.org\/10.1208\/s12249-018-1274-y.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"3416_CR74","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3892\/ijmm.2016.2458","volume":"37","author":"J Hu","year":"2016","unstructured":"Hu J, Wang J, Wang G, Yao Z, Dang X. Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells. Int J Mol Med. 2016;37(3):690\u2013702. https:\/\/doi.org\/10.3892\/ijmm.2016.2458.","journal-title":"Int J Mol Med"},{"key":"3416_CR75","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.foodhyd.2015.07.015","volume":"52","author":"BR Shah","year":"2016","unstructured":"Shah BR, Li Y, Jin W, An Y, He L, Li Z, et al. Preparation and optimization of pickering emulsion stabilized by chitosan-tripolyphosphate nanoparticles for curcumin encapsulation. Food Hydrocoll. 2016;52:369\u201377. https:\/\/doi.org\/10.1016\/j.foodhyd.2015.07.015.","journal-title":"Food Hydrocoll"},{"key":"3416_CR76","doi-asserted-by":"publisher","first-page":"41112","DOI":"10.1039\/C5RA04680G","volume":"5","author":"S Mirzaei","year":"2015","unstructured":"Mirzaei S, Khalilian MH, Taherpour AA. Mechanistic study of the hydrolytic degradation and protonation of temozolomide. RSC Adv. 2015;5:41112\u20139. https:\/\/doi.org\/10.1039\/C5RA04680G.","journal-title":"RSC Adv"},{"issue":"1","key":"3416_CR77","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/pharmaceutics14010129","volume":"14","author":"H Shah","year":"2022","unstructured":"Shah H, Madni A, Khan MM, Ahmad FUD, Jan N, Khan S, et al. pH-Responsive Liposomes of Dioleoyl Phosphatidylethanolamine and Cholesteryl Hemisuccinate for the Enhanced Anticancer Efficacy of Cisplatin. Pharmaceutics. 2022;14(1):129. https:\/\/doi.org\/10.3390\/pharmaceutics14010129.","journal-title":"Pharmaceutics"},{"issue":"8","key":"3416_CR78","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3390\/pharmaceutics16081036","volume":"16","author":"R Gil-Gonzalo","year":"2024","unstructured":"Gil-Gonzalo R, Durante-Salmer\u00f3n DA, Pouri S, Doncel-P\u00e9rez E, Alc\u00e1ntara AR, Aranaz I, et al. Chitosan-Coated Liposome Formulations for Encapsulation of Ciprofloxacin and Etoposide. Pharmaceutics. 2024;16(8):1036. https:\/\/doi.org\/10.3390\/pharmaceutics16081036.","journal-title":"Pharmaceutics"},{"key":"3416_CR79","doi-asserted-by":"publisher","unstructured":"Lee Y, Thompson DH. Stimuli-responsive liposomes for drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017;9(5)https:\/\/doi.org\/10.1002\/wnan.1450","DOI":"10.1002\/wnan.1450"},{"issue":"9","key":"3416_CR80","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1158\/1535-7163.MCT-18-1250","volume":"18","author":"A Renziehausen","year":"2019","unstructured":"Renziehausen A, Tsiailanis AD, Perryman R, Stylos EK, Chatzigiannis C, O\u2019Neill K, et al. Encapsulation of temozolomide in a calixarene nanocapsule improves its stability and enhances its therapeutic efficacy against glioblastoma. Mol Cancer Ther. 2019;18(9):1497\u2013505. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-1250.","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"3416_CR81","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/polym15030782","volume":"15","author":"D Pasarin","year":"2023","unstructured":"Pasarin D, Ghizdareanu AI, Enascuta CE, Matei CB, Bilbie C, Paraschiv-Palada L, et al. Coating materials to increase the stability of liposomes. Polymers (Basel). 2023;15(3):782. https:\/\/doi.org\/10.3390\/polym15030782.","journal-title":"Polymers (Basel)"},{"issue":"3","key":"3416_CR82","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3390\/polym14030650","volume":"14","author":"S Maiz-Fern\u00e1ndez","year":"2022","unstructured":"Maiz-Fern\u00e1ndez S, P\u00e9rez-\u00e1lvarez L, Silv\u00e1n U, Vilas-Vilela JL, Lanceros-M\u00e9ndez S. pH-induced 3D printable chitosan hydrogels for soft actuation. Polymers (Basel). 2022;14(3):650. https:\/\/doi.org\/10.3390\/polym14030650.","journal-title":"Polymers (Basel)"},{"issue":"5","key":"3416_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/md20050335","volume":"20","author":"P Mura","year":"2022","unstructured":"Mura P, Maestrelli F, Cirri M, Mennini N. Multiple roles of chitosan in mucosal drug delivery: an updated review. Mar Drugs. 2022;20(5):335. https:\/\/doi.org\/10.3390\/md20050335.","journal-title":"Mar Drugs"},{"issue":"3","key":"3416_CR84","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/polym10030267","volume":"10","author":"TMM Ways","year":"2018","unstructured":"Ways TMM, Lau WM, Khutoryanskiy VV. Chitosan and its derivatives for application in mucoadhesive drug delivery systems. Polymers (Basel). 2018;10(3):267. https:\/\/doi.org\/10.3390\/polym10030267.","journal-title":"Polymers (Basel)"},{"issue":"25","key":"3416_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202300319","volume":"12","author":"TB Gandek","year":"2023","unstructured":"Gandek TB, van der Koog L, Nagelkerke A. A comparison of cellular uptake mechanisms, delivery efficacy, and intracellular fate between liposomes and extracellular vesicles. Adv Healthc Mater. 2023;12(25):e2300319. https:\/\/doi.org\/10.1002\/adhm.202300319.","journal-title":"Adv Healthc Mater"},{"issue":"11","key":"3416_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103701","volume":"28","author":"HP Nijhawan","year":"2023","unstructured":"Nijhawan HP, Prabhakar B, Misra A, Yadav KS. Fragmented antibodies in non-small cell lung cancer: a novel nano-engineered delivery system for detection and treatment of cancer. Drug Discov Today. 2023;28(11):103701. https:\/\/doi.org\/10.1016\/j.drudis.2023.103701.","journal-title":"Drug Discov Today"},{"issue":"13","key":"3416_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29133131","volume":"29","author":"N Desai","year":"2024","unstructured":"Desai N, Rana D, Salave S, Benival D, Khunt D, Prajapati BG. Achieving endo\/lysosomal escape using smart nanosystems for efficient cellular delivery. Molecules. 2024;29(13):3131. https:\/\/doi.org\/10.3390\/molecules29133131.","journal-title":"Molecules"},{"issue":"1","key":"3416_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-01221-8","volume":"20","author":"P Zhang","year":"2022","unstructured":"Zhang P, Chen D, Li L, Sun K. Charge reversal nano-systems for tumor therapy. J Nanobiotechnology. 2022;20(1):31. https:\/\/doi.org\/10.1186\/s12951-021-01221-8.","journal-title":"J Nanobiotechnology"},{"key":"3416_CR89","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/bs.pmbts.2024.04.006","volume":"209","author":"PS Yasaswi","year":"2024","unstructured":"Yasaswi PS, Nijhawan HP, Prabhakar B, Dutt S, Yadav KS. Emerging drug delivery systems to alter tumor immunosuppressive microenvironment: overcoming the challenges in immunotherapy for glioblastoma. Prog Mol Biol Transl Sci. 2024;209:165\u201382. https:\/\/doi.org\/10.1016\/bs.pmbts.2024.04.006.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"3416_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2021.119848","volume":"258","author":"T Waghule","year":"2021","unstructured":"Waghule T, Narayan Saha R, Singhvi G. UV spectroscopic method for estimation of temozolomide: application in stability studies in simulated plasma pH, degradation rate kinetics, formulation design, and selection of dissolution media. Spectrochim Acta A Mol Biomol Spectrosc. 2021;258:119848. https:\/\/doi.org\/10.1016\/j.saa.2021.119848.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"19","key":"3416_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16193300","volume":"16","author":"M Duan","year":"2024","unstructured":"Duan M, Cao R, Yang Y, Chen X, Liu L, Ren B, et al. Blood\u2013brain barrier conquest in glioblastoma nanomedicine: strategies, clinical advances, and emerging challenges. Cancers (Basel). 2024;16(19):3300. https:\/\/doi.org\/10.3390\/cancers16193300.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"3416_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/biomimetics4020032","volume":"4","author":"M Collado-Gonz\u00e1lez","year":"2019","unstructured":"Collado-Gonz\u00e1lez M, Espinosa YG, Goycoolea FM. Interaction between chitosan and mucin: fundamentals and applications. Biomimetics (Basel). 2019;4(2):32. https:\/\/doi.org\/10.3390\/biomimetics4020032.","journal-title":"Biomimetics (Basel)"},{"issue":"4","key":"3416_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043390","volume":"24","author":"E Marcello","year":"2023","unstructured":"Marcello E, Chiono V. Biomaterials-enhanced intranasal delivery of drugs as a direct route for brain targeting. Int J Mol Sci. 2023;24(4):3390. https:\/\/doi.org\/10.3390\/ijms24043390.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3416_CR94","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/1061186X.2022.2119243","volume":"31","author":"J Yang","year":"2023","unstructured":"Yang J, Xu Y, Fu Z, Chen J, Fan W, Wu X. Progress in research and development of temozolomide brain-targeted preparations: a review. J Drug Target. 2023;31(2):119\u201333. https:\/\/doi.org\/10.1080\/1061186X.2022.2119243.","journal-title":"J Drug Target"},{"issue":"5","key":"3416_CR95","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000528969","volume":"184","author":"R Zhang","year":"2023","unstructured":"Zhang R, Zhang L, Li P, Pang K, Liu H, Tian L. Epithelial barrier in the nasal mucosa, related risk factors and diseases. Int Arch Allergy Immunol. 2023;184(5):481\u2013501. https:\/\/doi.org\/10.1159\/000528969.","journal-title":"Int Arch Allergy Immunol"},{"issue":"7","key":"3416_CR96","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3109\/10717544.2014.885999","volume":"22","author":"K Jain","year":"2015","unstructured":"Jain K, Sood S, Gowthamarajan K. Optimization of artemether-loaded NLC for intranasal delivery using central composite design. Drug Deliv. 2015;22(7):940\u201354. https:\/\/doi.org\/10.3109\/10717544.2014.885999.","journal-title":"Drug Deliv"},{"issue":"6","key":"3416_CR97","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1021\/acs.chemrev.3c00608","volume":"124","author":"G Duch\u00e9","year":"2024","unstructured":"Duch\u00e9 G, Sanderson JM. The chemical reactivity of membrane lipids. Chem Rev. 2024;124(6):3284\u2013330. https:\/\/doi.org\/10.1021\/acs.chemrev.3c00608.","journal-title":"Chem Rev"},{"issue":"5","key":"3416_CR98","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-022-02282-0","volume":"23","author":"J Musakhanian","year":"2022","unstructured":"Musakhanian J, Rodier JD, Dave M. Oxidative stability in lipid formulations: a review of the mechanisms, drivers, and inhibitors of oxidation. AAPS PharmSciTech. 2022;23(5):151. https:\/\/doi.org\/10.1208\/s12249-022-02282-0.","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"3416_CR99","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s13346-023-01477-7","volume":"14","author":"S Arora","year":"2024","unstructured":"Arora S, Dash SK, Dhawan D, Sahoo PK, Jindal A, Gugulothu D. Freeze-drying revolution: unleashing the potential of lyophilization in advancing drug delivery systems. Drug Deliv Transl Res. 2024;14(5):1111\u201353. https:\/\/doi.org\/10.1007\/s13346-023-01477-7.","journal-title":"Drug Deliv Transl Res"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03416-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03416-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03416-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:50:50Z","timestamp":1780390250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03416-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":99,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3416"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03416-4","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) confirm that they received the necessary institutional board of approval for the study. All experiments were conducted following the guidelines of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CSPCSEA), India. The study was approved by the Institutional Animal Ethics Committee of SVKM\u2019s NMIMS, under approval number: CPCSEA\/IAEC\/P-38\/2025.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"All author(s) have read the manuscript and provided their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Clinical trial number not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trials"}},{"value":"The author(s) declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}],"article-number":"179"}}